Fundz

Quanthealth Secures Funding From Accenture And Other Investors To Deliver Ai-Powered Clinical Trial Simulations For Pharmaceutical And Biotech Companies

PRIVATEJan 08, 2024

Round Type

Funding Round

Tel AvivBiotechnologyHealth Careresearch

Investors

Accenture Ventures

Description

QuantHealth, an AI-powered clinical trial design company that simulates clinical trials, today announced it has received a strategic investment from Accenture Ventures along with participation from a leading CRO firm and additional investors. The new capital brings the total A round amount to $17M and will enable QuantHealth to enhance its platform used by pharmaceutical and biotech companies to save millions on clinical trials and drug development.

Quick answer

QuantHealth raised an undisclosed amount in a Funding Round round, dated January 8, 2024. Investors: Accenture Ventures. QuantHealth is based in Tel Aviv, Tel Aviv District, Israel.

How much did QuantHealth raise?
QuantHealth raised an undisclosed amount in a Funding Round round on January 8, 2024.
Who invested in QuantHealth?
Accenture Ventures is named as investors in this round.
What does QuantHealth do?
QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development.
Where is QuantHealth based and how big is it?
QuantHealth is based in Tel Aviv, Tel Aviv District, Israel. Fundz records about 62 employees.
Who are the decision-makers at QuantHealth?
Fundz holds 1 contact at QuantHealth. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as QuantHealth that raised within 45 days of this round, from Fundz verified event records.

  • FOXO Technologies raised $3.5M on January 19, 2024.
  • Cadenza Bio raised an undisclosed amount (Funding Round) on December 20, 2023.
  • Cadenza Bio raised $2.4M (Seed) on December 14, 2023.
  • Frontier Medicines Corp raised $80M (Series C) on February 22, 2024.
  • Samphire Neuroscience raised $2.3M (Pre-Seed) on February 21, 2024.
  • Medical Microinstruments raised $110M (Series C) on February 21, 2024.

Who to call at QuantHealth, and when

A new round usually means QuantHealth is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day QuantHealth raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QuantHealth, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QuantHealth. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QuantHealth

Location

8 הארבעה

Tel Aviv, Tel Aviv District, Israel

About

QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QuantHealth raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for QuantHealth's next move

See what Strategic adds

QuantHealth raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.